Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
NovoraySHSE:688300 +1.39%79 EV-to-EBIT is 121.46 as of Sep. 22, 2026, which is 215% above its 10-year median of 38.52. GuruFocus rates SHSE:688300 with a GF Score™ of 79/100 and a GF Value™ of ¥70.94 (Significantly Overvalued). The stock has 2 warning signs investors should review. Among 1,291 Chemicals companies, Novoray ranks worse than 94.73% on this metric.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Novoray's Enterprise Value is ¥42,430 Mil.
Novoray's EBIT for the trailing twelve months (TTM) ended in Jun. 2026 was ¥349 Mil. Therefore, Novoray's EV-to-EBIT for today is 121.46.
The historical rank and industry rank for Novoray's EV-to-EBIT or its related term are showing as below:
SHSE:688300'
s EV-to-EBIT Range Over the Past 10 Years
Min: 24.07 Med: 38.52 Max: 185.77
Current: 121.46
During the past 10 years, the highest EV-to-EBIT of Novoray was 185.77. The lowest was 24.07. And the median was 38.52.
SHSE:688300's EV-to-EBIT is ranked worse than 94.73% of 1291
companies
in the Chemicals industry
Industry Median: 16.68
vs SHSE:688300: 121.46
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Novoray's Enterprise Value for the quarter that ended in Jun. 2026 was ¥58,644 Mil.
Novoray's EBIT for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥349 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Novoray EV-to-EBIT Related Terms
Novoray EV-to-EBIT Historical Data
* Premium members only.
The historical data trend for Novoray's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SHSE:688300 vs LIN, SHW, ECL: EV-to-EBIT Comparison
For the Specialty Chemicals subindustry, Novoray's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Novoray EV-to-EBIT vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Novoray's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Novoray's EV-to-EBIT falls into.
Novoray's current Enterprise Value is ¥42,430 Mil.
Novoray's EBIT for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥349 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Novoray (SHSE:688300) has a EV-to-EBIT of 121.46 as of Sep. 22, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Novoray and its competitors. This is 215% above median its historical median of 38.52. Over the past decade, Novoray's EV-to-EBIT has ranged from 24.07 to 185.77. According to the industry distribution chart, Novoray ranks #1223 out of 1291 companies in the Chemicals industry, placing it in the top 94.7%.
Is Novoray's EV-to-EBIT too high?
Novoray's current EV-to-EBIT of 121.46 is 215% above median its 10-year median of 38.52. Over the past 10 years, this metric has ranged from a low of 24.07 to a high of 185.77. The Chemicals industry median EV-to-EBIT is 16.68. Novoray's value of 121.46 is 628.2% above this industry median. Based on the distribution chart, Novoray ranks #1223 out of 1291 companies in the Chemicals industry, which is in the bottom quartile relative to peers. Overall, Novoray has a GF Score™ of 79/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Novoray's EV-to-EBIT compare to LIN and SHW?
According to the Chemicals industry distribution chart, Novoray ranks #1223 out of 1291 companies for EV-to-EBIT. This places Novoray in the lower half of its industry. The industry median EV-to-EBIT is 16.68. Novoray's value of 121.46 is 628.2% above this benchmark. Historically, Novoray's own EV-to-EBIT has ranged from 24.07 to 185.77 over the past decade. While the company's 10-year median is 38.52 vs. the industry median of 16.68, Novoray has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Chemicals company?
The median EV-to-EBIT among Chemicals companies is 16.68, based on 1,291 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Novoray's current EV-to-EBIT of 121.46 is 628.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Novoray and its competitors. For the Chemicals industry, the median EV-to-EBIT is 16.68 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Novoray's current EV-to-EBIT is 121.46, which is 215% above median its own 10-year median of 38.52. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Novoray stock overvalued right now?
Based on GuruFocus' analysis, Novoray (SHSE:688300) is currently considered Significantly Overvalued. The stock's GF Value™ is ¥70.94, compared to a current price of ¥177.21 — trading 149.8% above its estimated fair value. The current EV-to-EBIT is 121.46, which is 215% above median its 10-year median of 38.52 and 628.2% above the Chemicals industry median of 16.68. Novoray's overall GF Score™ is 79/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For Novoray (SHSE:688300), the current EV-to-EBIT is 121.46 as of Sep. 22, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Novoray (SHSE:688300) Overvalued in 2026?
Based on GuruFocus' analysis, Novoray stock appears to be overvalued.
The current stock price of ¥177.21 is trading 149.8% above its estimated GF Value™ of ¥70.94.
GuruFocus considers Novoray to be Significantly Overvalued.
Key valuation signals for SHSE:688300:
EV-to-EBIT: 121.46 (215% above median its 10-year median of 38.52)
GF Value™: ¥70.94 vs. price of ¥177.21 (149.8% above fair value)
Industry Position: 628.2% above the Chemicals median (#1223 of 1291)
No single metric tells the full story. See the SHSE:688300 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688300 has been successfully added to your 
